Delivery Order SPE2DB24D9230-SPE2DB24FHVPE

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,245.40 firm fixed-price delivery order is for the provision of XTANDI 40 mg capsules under a larger indefinite delivery contract (IDC) valued at up to $499,999,999. This single-award IDC, designated SPE2DB, allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,868.10 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, to support the recurring medical needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,934.05, is a firm fixed-price delivery order for the supply of XTANDI 40 MG CAPSULE 120S to the DLA. The order has an ultimate completion date of June 17, 2024 and was awarded on June 14, 2024. This contract is part of a larger...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,934.05, is for the delivery of XTANDI 40 MG CAPSULE 120S to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded by the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,311.35 firm fixed-price delivery order covers the provision of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,172.47 firm-fixed-price delivery order is for the provision of XTANDI 40 MG CAPSULE 120S, a prescription drug, to support the recurring medical supply needs of military health facilities. The award is under the DLA's SPE2DB program, which is a $499,999,999 indefinite delivery contract (IDC) that...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,934.05, is for the delivery of XTANDI 40 MG CAPSULE 120S. This order is placed under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group held by the DLA, valued at up to $499,999,999 and running through December 31, 2025. The IDC...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,622.72 firm fixed-price delivery order contract is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) vehicle under the DLA's SPE2DB program, which allows for the issuance of delivery orders for...
This federal contract award was granted by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,245.40 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,622.72 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
  • SPE2DB24D9230
    Indefinite Delivery Contract
  • SPE2DB24D9230-SPE2DB24FHVPE
    Delivery Order

The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,442.82 firm fixed-price delivery order is for the provision of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) under the SPE2DB program, valued up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation. Through this IDC and other prime vendor contracts, DMS Pharmaceutical Group serves as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and specialized medications to the Department of Defense and its healthcare facilities globally.

Generated 10/23/24, 9:22 AM